Harvard Bioscience (United States)
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company has 20 wholly owned subsidiaries. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Harvard Bioscience (United States), United States, covering academic research published from 2001 to 2023. Read More.
Open Access Percentage
83%
Total
Publications
102
Total Open
Publications
85
Total
Citations
5K
Open Access
Percentage
83%
Total
Publications
102
Total Open
Publications
85
Total
Citations
5K
Breakdown
Publisher Open
11%
Both
46%
Other Platform Open
26%
Closed
17%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 31%
18
Hybrid 43%
25
No Guarantees 26%
15
Other Platform Open
Domain 70%
52
Institution 34%
25
Preprint 26%
19
Other Internet 15%
11
Public 9%
7
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 52 |
Europe PMC | Domain | 38 |
DOI | Other Internet | 29 |
bioRxiv | Preprint | 18 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 12 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 8 |
Massachusetts Institute of Technology - DSpace@MIT | Institution | 7 |
Semantic Scholar | Public | 4 |
Figshare | Public | 4 |
California Institute of Technology - CaltechAUTHORS | Institution | 4 |